A blood-based biomarker assay for multiple sclerosis (MS) disease activity provides actionable insights that supplement standard MS evaluations, especially for treatment initiation and de-escalation ...

There may be two distinct subtypes of multiple sclerosis, according to a new study led by scientists at University College ...

MS research suggests the disease may be divided into two biological subtypes that differ in how early and aggressively nerve ...

Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...

A research team at the Medical University of Vienna has developed a blood test that allows the identification of individuals at risk for developing multiple sclerosis (MS) with a high degree of ...

LONDON — Previous research has shown that providing a clinically definite multiple sclerosis (MS) diagnosis often takes several weeks or even months. But new research suggests that a new "technology ...

Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Across the United States Collaboration ...

Research shows that Blacks may develop multiple sclerosis more often than previously thought. Additionally, the symptoms of ...